MedPath

FIBRYGA

FIBRYGA

Approved
DIN Number

02464616

Drug Class

Human

Market Date

Aug 8, 2018

Company
HC

octapharma pharmazeutika produktionsges m b h

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02464616
AIG Number0153289002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
B02BB01 FIBRINOGEN, HUMAN
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification20:28.16
Health Canada Classification

ACTIVE INGREDIENTS (1)

FIBRINOGEN (HUMAN)Active
Strength: 1 G / VIAL
Monograph: FIBRINOGEN (HUMAN)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.